Skip to main content

This handheld DNA sequencer could let regular civilians analyze genetic material

It used to be that Star Trek’s infamous Tricorder device only existed in the realm of science fiction, but a real-life working version is bringing Trekkie tech to the real world, and helping humanity detect, analyze and diagnose illness in a whole new way. MinION, as it’s called, is a fully portable handheld DNA sequencer that can not only detect the presence of an infection, but also estimate the severity of disease before the outbreak gets out of hand.

In the Star Trek universe, doctors used the medical Tricorder device to collect bodily information about their patients. Sometimes it was used to distinguish specific diseases or illnesses, or sometimes to diagnose new or alien health conditions. The name comes from the full name of the fictional device, the tri-function recorder, since it was used for three purposes: to sense, compute, and record patient data.

Recommended Videos

In real life, this medical device will be able to scan and analyze patient samples virtually anywhere. Doctors will be able to scan sick patients’ breath to identify bacteria causing curious illnesses. Health workers will be able to detect dangerous microbes spreading infections in hospitals. And beyond its health-specific applications, the MinION will also be useful in agricultural regulation, fresh produce, and food processing checks, and could even play an important role in protecting endangered animal species from diseases and the risks of illegal trafficking.

nanopore
Image used with permission by copyright holder

Inventors and researchers working on the MinION project are proponents of what has come to be known as “the democratization of sequencing”. DNA makes up the building blocks of life on Earth, but has largely been inaccessible to civilians and individuals outside research labs and the medical profession. The handheld MinION device is another step towards a world where anyone can gather information and process DNA samples for their own personal purposes. Nanopore technology allows an ionic current to pass through nano-scale holes in the device, measuring changes in the current to identify the biological components of molecules as they progress through the system.

Genetics is an intricate and influential field of science, but the study of DNA also leads to controversial conversations about how future applications of sequencing technology could be highly dangerous or even outright wrong. Assessing genetic suitability for certain tasks is an idea framed by popular culture in the 1997 film, Gattaca. In the movie, DNA from strands of hair was analyzed to determine the hierarchy of suitability for potential astronauts launching into space. As Gattaca fans will remember, DNA sequencing starts a slippery slope from real genetic science to social philosophy built on theories of eugenics.

The MinION device itself is 10 centimeters long and weighs 90 grams, and its portability is matched by its $1000 price tag. This is an affordable option for professionals and scientists, especially when compared to the high costs of other DNA sequencing technologies. MinION could be a game-changer in the medical and biotech fields, since the device could eliminate the costly/time-consuming need to ship DNA samples to research labs.

An improved turnaround time for DNA sequencing results could be the difference between life and death in situations where dangerous contagions are at play. Looking back on outbreaks of Ebola or even Avian flu in recent years, it’s clear to see that MinION could significantly stifle the spread of dangerous diseases in the remote locations where they often originate. In time, the MinION device could even become an important teaching tool, as DNA sequencing becomes more accessible for interested civilians. If the democratization of sequencing takes hold as a movement, MinION data could even be linked to smart phones so that illnesses could be diagnosed in real time wherever they occur..

Chloe Olewitz
Former Digital Trends Contributor
Chloe is a writer from New York with a passion for technology, travel, and playing devil's advocate. You can find out more…
The Ioniq 5 is once again eligible for the $7,500 tax credit
2025 Hyundai Ioniq 5

After a brief and confusing absence, the Hyundai Ioniq 5 is once again eligible for the full $7,500 federal tax credit — and this time, it's sticking around (at least for now). So, what happened? Let’s unpack the ride.

The Ioniq 5, a sleek and tech-savvy electric crossover, initially made headlines not just for its design, but for being built at Hyundai’s brand-new Metaplant in Georgia. That domestic assembly qualified it for the EV tax credit under the Inflation Reduction Act (IRA), which requires vehicles to be made in North America with batteries sourced from trade-friendly countries. But early in 2025, the Ioniq 5 vanished from the list. Why? Likely due to its battery packs, which were then still being sourced from SK On’s Hungarian facility.

Read more
Sebastian Stan lays out Bucky’s future after Thunderbolts
Sebastian Stan in Thunderbolts.

There are some spoilers ahead for the ending of Marvel's Thunderbolts. Stop reading now if you don't want to be spoiled.

Earlier this year, Captain America: Brave New World briefly introduced a new direction for James "Bucky" Barnes, a character Sebastian Stan has been playing since 2011 in Captain America: The First Avenger. In Brave New World, the former Winter Soldier apparently retired from being a reformed hero and went into politics by running for Congress. Thunderbolts reveals that Bucky won his election to the House of Representatives. But his stay in Congress was short.

Read more
Jeep Compass EV breaks cover—but will it come to the U.S.?
jeep compass ev us newjeepcompassfirsteditionhawaii  4

Jeep just pulled the wraps off the all-new Compass EV, and while it’s an exciting leap into the electric future, there's a catch—it might not make it to the U.S. anytime soon.
This is a brand new electric version of the Jeep Compass, and being built on Stellantis' STLA platform—the same architecture underpinning models like the Peugeot E-3008 and E-5008—it looks much slicker and packs a lot more inside than previous versions of the Compass.
Let’s start with what’s cool: the new Compass EV is packing up to 404 miles of range on a single charge, a 74 kWh battery, and fast-charging that gets you from 20% to 80% in about 30 minutes. Not bad for a compact SUV with Jeep's badge on the nose.
There are two versions: a front-wheel-drive model with 213 horsepower and a beefier all-wheel-drive version with 375 horsepower. That AWD setup isn’t just for looks—it can handle 20% inclines even without front traction, and comes with extra ground clearance and better off-road angles. In short, it’s still a Jeep.
The design's been refreshed too, and inside you’ll find the kind of tech and comfort you’d expect in a modern EV—sleek, smart, and ready for both city streets and dirt trails.
But here’s the thing: even though production starts soon in Italy, Jeep hasn’t said whether the Compass EV is coming to America. And the signs aren’t promising.
Plans to build it in Canada were recently put on hold, with production now delayed until at least early 2026. Some of that might have to do with possible U.S. tariffs on Canadian and Mexican vehicles—adding a layer of uncertainty to the whole rollout.
According to Kelley Blue Book, a Stellantis spokesperson confirmed that the company has “temporarily paused work on the next-generation Jeep Compass, including activities at” the Canadian plant that was originally meant to build the model. They added that Stellantis is “reassessing its product strategy in North America” to better match customer needs and demand for different powertrain options.
So while Europe and other markets are gearing up to get the Compass EV soon, American drivers might be left waiting—or miss out entirely.
That’s a shame, because on paper, this electric Jeep hits a lot of sweet spots. Let’s just hope it finds a way over here.

Read more